findmyKOL

Gabriel Hortobagyi, MD

Enriched profile

Professor and Chair Emeritus, Department of Breast Medical Oncology (Nellie B. Connally Chair in Breast Cancer, emeritus), The University of Texas MD Anderson Cancer Center · The University of Texas MD Anderson Cancer Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Houston, TX · South Central · United StatesSpecialtyMedical OncologyFocusBreast Cancer Treatment Studies+4
Active KOLfindmyKOL type: RegionalLatest publication2025Online presenceverified 2026Payments2021–2023NIH funding1992–2009

Gabriel Hortobagyi is Professor and Chair Emeritus, Department of Breast Medical Oncology (Nellie B. Connally Chair in Breast Cancer, emeritus), The University of Texas MD Anderson Cancer Center at The University of Texas MD Anderson Cancer Center. OpenAlex indexes 1,905 publications with 140,837 citations (h-index 187); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Medical Oncology profiles in the findmyKOL directory. Clarivate lists Gabriel Hortobagyi as a Highly Cited Researcher (Clinical Medicine, 2014-2016, 2018-2021; Cross-Field, 2022-2024).

Data verified 16 Oct 2026

Overview

Updated 16 Oct 2026

Gabriel N. Hortobagyi, M.D., is Professor and Chair Emeritus, Department of Breast Medical Oncology (Nellie B. Connally Chair in Breast Cancer, emeritus), The University of Texas MD Anderson Cancer Center. The public record shows 1,905 publications with 140,837 citations (h-index 187), centered on Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 8 companies, 2 NIH-funded awards (1992–2009).

  • Most recent indexed publication: 2025 · Journal of clinical oncology
  • Top research focus: Breast Cancer Treatment Studies
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 8 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Breast Cancer1 trial

Research focus

OpenAlex concept fingerprint
Breast Cancer Treatment StudiesCancer Treatment and PharmacologyHER2/EGFR in Cancer ResearchAdvanced Breast Cancer TherapiesBreast Lesions and Carcinomas

Drugs & molecules

across trials, industry payments and publications
Kisqaligeneric · RibociclibClinical trials—Industry payments4Publications5AnastrozoleClinical trials1Industry payments—Publications2GoserelinClinical trials1Industry payments—Publications—Ibrancegeneric · PalbociclibClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
AstraZeneca Pharmaceuticals LPClinical trials—Industry payments3Novartis Pharmaceuticals CorporationClinical trials—Industry payments3Blueprint Medicines CorporationClinical trials—Industry payments1Covis Pharma GmBHClinical trials—Industry payments1Gilead Sciences, Inc.Clinical trials—Industry payments1Insmed, Inc.Clinical trials—Industry payments1Novartis Pharma AGClinical trials—Industry payments1Pfizer Inc.Clinical trials—Industry payments1SWOG Cancer Research NetworkClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,905publications

Distinct works indexed by OpenAlex, matched via ORCID; 37 in PubMed.

140,837citations

Total citations across indexed works.

187h-index

Hirsch index (OpenAlex). i10-index 938.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
8companies · 2021–2023

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 1992–2009

Federally funded research awards.

View funding ↓

Public positions

sourced statements on record

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

8 companies reported payments to CMS in program years 2021–2023. These are public disclosures, not judgments. The latest:

All 9 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2021)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    100%
    Kinase inhibitor100%
    Ibrance100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

2 NIH research awards on record, funded 1992–2009 per NIH RePORTER. The latest:

All 17 award records: search, sort and filter.Explore →

Congress activity

Updated 16 Oct 2026

212 congress contributions (2003–2025) across AACR, ASCO, ASTRO, ESMO, SABCS per OpenAlex. The most recent:

All 212 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 37 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
    2,907 citations2008
    doi.org ↗
  2. 02
    Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
    2,832 citations2011
    doi.org ↗
  3. 03
    Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
    2,014 citations2016
    doi.org ↗
  4. 04
    Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
    1,888 citations2005
    doi.org ↗
  5. 05
    PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
    1,869 citations2004
    doi.org ↗
All 1,905 cited works: search, sort and filter.Explore →

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Vicente Valero352Naoto T. Ueno301Lajos Pusztai288Aman U. Buzdar269W. Fraser Symmans210Ayşegül A. Şahin186Ana M. González-Angulo178Debu Tripathy163Mien‐Chie Hung157Savitri Krishnamurthy150Francisco J. Esteva138Thomas A. Buchholz130Gordon B. Mills126Massimo Cristofanilli125Banu Arun123Jennifer K. Litton122Funda Meric‐Bernstam118William E. Barlow115Kelly K. Hunt112Richard L. Theriault108Daniel J. Booser100Weiya Xia93Julie R. Gralow89Nuhad K. Ibrahim89Mary Kathryn Pitner85Chandra Bartholomeusz85Daniel F. Hayes83Stacy L. Moulder81Henry M. Kuerer81Bryan T. Hennessy80Wendy A. Woodward78Aňa Lluch77Elizabeth A. Mittendorf75Kathy S. Albain75Kristine Broglio74Keith Baggerly74Hirohito Yamaguchi73Sharon H. Giordano68Takahiro Kogawa68Diane D. Liu68

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/gabriel-hortobagyi-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Gabriel-N-Hortobagyi-2156318271

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Gabriel-N-Hortobagyi-MD-80160161

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • YouTube

    YouTube video: 'Dr. Gabriel Hortobagyi (UT MD Anderson Cancer Center) on impact of BCRF Funding'

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    MD Anderson 'Cancerwise' podcast playlist (institution-owned) -- could not confirm whether a Hortobagyi-specific episode exists after 3 attempts

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • X / Twitter

    X post by Dr. Sara Tolaney (@stolaney1, Oct 9 2024): 'An honor to give the Gabriel Hortobagyi lecture at MD Anderson today' -- confirms an eponymous honorary lecture exists at MD Anderson

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • X / Twitter

    MD Anderson newsroom coverage of MONALEESA-2 trial explicitly naming Gabriel Hortobagyi, MD, professor of Breast Medical Oncology -- plausible source for @MDAndersonNews institutional tweets …

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →twitter.com ↗
  • Mdanderson.org

    MD Anderson newsroom - Two MD Anderson faculty named as prestigious AAAS Fellows (references Hortobagyi)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdanderson.org ↗
  • Cancerletter.com

    The Cancer Letter - Awards to be presented at ASCO annual meeting (references Hortobagyi 2018 Bonadonna award)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancerletter.com ↗
  • Onclive.com

    OncLive - Searching for Possibilities, Hortobagyi Found Greatness (profile feature)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
  • Patientresource.com

    Patient Resource - Global Advisory Board: Gabriel N. Hortobagyi

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →patientresource.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Scientific Advisory Board member (1994-2022) and SAB Chair (2018-2019)

    Breast Cancer Research Foundation

    2019
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
  • Past President

    American Society of Clinical Oncology (ASCO), 2006-2007

    2007
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
  • Chair

    Southwest Oncology Group (SWOG) breast committee, since 2007

    2007
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bcrf.org ↗
  • Past President

    American Society of Clinical Oncology (ASCO), 2006-2007

    2007
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
  • Founding Chair

    Department of Breast Medical Oncology, MD Anderson (1992-2012); Chief of Section, Breast Medical Oncology

    1992
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
  • Program Director

    Susan G. Komen Interdisciplinary Breast Fellowship Program, MD Anderson

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
  • Editor Emeritus

    The Oncologist (Oxford Academic)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →academic.oup.com ↗
  • Professional Advisory Board member

    Breastcancer.org

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →breastcancer.org ↗
  • Past President

    International Society of Senology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
  • Former Chair

    Steering Committee of the Breast Health Global Initiative

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
  • Immediate Past Chair

    Southwest Oncology Group (SWOG) Breast Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗

Highly Cited Researcher

Clarivate's annual list, by award category and year
  • Clinical Medicine
    2014201520162018201920202021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
  • Cross-Field
    202220232024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Breast Cancer Research Foundation (BCRF) - Investigator since 1994; Scientific Advisory Board Chair (2018-2019); now Scientific Advisory Board Member

    Emeritus

    2019
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
  • President

    International Society of Senology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bcrf.org ↗
  • Chair

    Steering Committee, Breast Health Global Initiative

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bcrf.org ↗
  • Member

    U.S. National Committee for the International Union Against Cancer

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bcrf.org ↗
  • Member

    National Cancer Institute's Breast Cancer Progress Review Group

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bcrf.org ↗
  • Professional Advisory Board Member

    Breastcancer.org

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →breastcancer.org ↗
  • Chairman

    Medical Advisory Board, Agendia

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →agendia.com ↗
  • Holder

    Nellie B. Connally Chair in Breast Cancer, MD Anderson

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →breastcancer.org ↗
  • Program Director

    Susan G. Komen Interdisciplinary Breast Fellowship Program, MD Anderson

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.